Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-13-043961)

Filing Details

Accession Number:: 0001104659-13-043961
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-22 17:30:17
Reporting Period:: 2013-05-21

Filing Date:: 2013-05-22
Accepted Time:: 2013-05-22 17:30:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130166	Cyclacel Pharmaceuticals Inc.	CYCC	Pharmaceutical Preparations (2834)	911766850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1357397	Paul Mcbarron	200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922	Evp, Finance, Cfo, Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2013-05-21	8,333	$3.00	65,481	No	4	P	Direct
Common Stock, $0.001 Par Value Per Share	Acquisiton	2013-05-21	4,615	$3.08	70,096	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 30,714 shares are represented by unvested restricted stock units.